Integrated PBPK-EO modeling of osimertinib to predict plasma concentrations and intracranial EGFR engagement in patients with brain metastases
Crossref DOI link: https://doi.org/10.1038/s41598-024-63743-z
Published Online: 2024-06-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liang, Feng
Zhang, Yimei
Xue, Qian
Zhang, Xiaoling
Text and Data Mining valid from 2024-06-03
Version of Record valid from 2024-06-03
Article History
Received: 10 January 2024
Accepted: 31 May 2024
First Online: 3 June 2024
Competing interests
: The authors declare no competing interests.